$183 Million is the total value of Tamarack Advisers, LP's 32 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 87.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | NOVOCURE LTD | $21,311,000 | +44.4% | 1,055,000 | +41.9% | 11.63% | +28.7% | |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTI | $20,006,000 | -4.7% | 1,375,000 | -6.8% | 10.92% | -15.0% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $14,380,000 | +53.2% | 315,000 | +26.0% | 7.85% | +36.6% |
| LH | Buy | LABORATORY CRP OF AMER HLDGS | $12,761,000 | +40.9% | 80,000 | +33.3% | 6.96% | +25.6% |
| NUVA | Buy | NUVASIVE INC | $12,303,000 | +38.6% | 210,340 | +31.5% | 6.72% | +23.6% |
| MDT | Sell | MEDTRONIC PLC | $12,113,000 | -5.6% | 150,000 | -9.1% | 6.61% | -15.8% |
| QDEL | Buy | QUIDEL CORP | $11,705,000 | +77.9% | 270,000 | +80.0% | 6.39% | +58.6% |
| CORI | Buy | CORIUM INTERNATIONAL INC | $9,706,000 | -7.8% | 1,010,000 | +6.3% | 5.30% | -17.8% |
| GILD | Buy | GILEAD SCIENCES INC | $9,313,000 | -8.0% | 130,000 | +4.0% | 5.08% | -18.0% |
| NXTM | New | NXSTAGE MEDICAL INC | $6,663,000 | – | 275,000 | +100.0% | 3.64% | – |
| NKTR | Sell | NEKTAR THERAPEUTICS | $6,271,000 | -52.5% | 105,000 | -80.9% | 3.42% | -57.6% |
| DGX | New | QUEST DIAGNOSTICS INC | $4,925,000 | – | 50,000 | +100.0% | 2.69% | – |
| SRCL | Sell | STERICYCLE INC | $4,191,000 | -52.4% | 61,641 | -49.9% | 2.29% | -57.6% |
| OBLN | Buy | OBALON THERAPEUTICS INC | $3,993,000 | -23.5% | 604,036 | +10.3% | 2.18% | -31.8% |
| MCK | New | MCKESSON CORP | $3,899,000 | – | 25,000 | +100.0% | 2.13% | – |
| ALKS | New | ALKERMES PLC | $3,831,000 | – | 70,000 | +100.0% | 2.09% | – |
| SCI | New | SERVICE CORP INTERNATIONAL | $3,732,000 | – | 100,000 | +100.0% | 2.04% | – |
| ATRC | Buy | ATRICURE INC | $3,192,000 | +42.7% | 175,000 | +75.0% | 1.74% | +27.2% |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $3,138,000 | – | 92,600 | +100.0% | 1.71% | – |
| LNTH | Buy | LANTHEUS HOLDINGS INC | $3,076,000 | +32.9% | 150,437 | +15.7% | 1.68% | +18.5% |
| CRME | Buy | CARDIOME PHARMA CORP | $2,906,000 | -22.0% | 1,875,000 | +7.1% | 1.59% | -30.5% |
| OPHT | Sell | OPHTHOTECH CORP | $2,340,000 | +7.0% | 750,000 | -3.2% | 1.28% | -4.6% |
| STE | New | STERIS PLC | $2,187,000 | – | 25,000 | +100.0% | 1.19% | – |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $1,775,000 | +15.3% | 1,050,000 | +0.3% | 0.97% | +2.9% |
| RCM | Sell | R1 RCM INC | $1,764,000 | +11.9% | 400,000 | -5.9% | 0.96% | -0.3% |
| HCA | New | HCA US 01/19/18 C80call | $845,000 | – | 1,000 | +100.0% | 0.46% | – |
| BSX | New | BSX US 01/19/18 P27put | $328,000 | – | 1,500 | +100.0% | 0.18% | – |
| XLV | New | XLV US 01/19/18 P84put | $230,000 | – | 2,000 | +100.0% | 0.13% | – |
| SPY | New | SPY US 01/19/18 P255put | $168,000 | – | 4,000 | +100.0% | 0.09% | – |
| IWM | New | IWM US 01/19/18 P146put | $96,000 | – | 2,000 | +100.0% | 0.05% | – |
| TMO | New | TMO US 01/19/18 P195put | $54,000 | – | 100 | +100.0% | 0.03% | – |
| SHPG | New | SHPG US 01/19/18 C185call | $5,000 | – | 394 | +100.0% | 0.00% | – |
| Exit | ALR US 10/20/17 P50put | $0 | – | -1,000 | -100.0% | -0.01% | – | |
| Exit | BAX US 10/20/17 P62.5put | $0 | – | -250 | -100.0% | -0.01% | – | |
| Exit | SHPG US 01/19/18 C185call | $0 | – | -750 | -100.0% | -0.06% | – | |
| Exit | SPY US 10/20/17 P240put | $0 | – | -4,000 | -100.0% | -0.06% | – | |
| Exit | IWM US 11/17/17 P140put | $0 | – | -4,500 | -100.0% | -0.11% | – | |
| Exit | SYK US 11/17/17 P145put | $0 | – | -350 | -100.0% | -0.12% | – | |
| Exit | HSIC US 01/19/18 P87.5put | $0 | – | -400 | -100.0% | -0.18% | – | |
| Exit | HCA US 01/19/18 C80call | $0 | – | -1,121 | -100.0% | -0.28% | – | |
| Exit | ESRX US 01/19/18 C60call | $0 | – | -1,000 | -100.0% | -0.31% | – | |
| SIEN | Exit | SIENTRA INCequity | $0 | – | -60,000 | -100.0% | -0.57% | – |
| EVH | Exit | EVOLENT HEALTH INC - Aequity | $0 | – | -75,000 | -100.0% | -0.82% | – |
| XRAY | Exit | DENTSPLY SIRONA INCequity | $0 | – | -50,000 | -100.0% | -1.83% | – |
| CVS | Exit | CVS HEALTH CORPequity | $0 | – | -75,000 | -100.0% | -3.73% | – |
| STE | Exit | STERIS PLCequity | $0 | – | -70,000 | -100.0% | -3.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.